TMS

The submission references a legitimate Japanese pharmaceutical entity (TMS Co., Ltd.) but suffers from critical credibility issues. The provided URL and email contain typos (.jpen), the submitter name ('ThunderWalker') is unprofessional, and the traction claim ('most people have used my product') is demonstrably false for a clinical-stage biotech company. While the underlying company has real-world utility, the submission itself lacks verifiable evidence and appears to be spam or a low-quality entry.